Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD - Causes of Hashimoto's (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD discusses Hasimoto’s thyroiditis at the LDN 2019 Conference. He discusses the mechanisms of thyroid dysfunction, causes and evaluation of Hashimoto’s thyroiditis, Hashimoto’s in obesity, and treatments of Hasimoto's
 

Igor Schwartzman, ND - The Art of LDN Prescribing In Hashimoto’s Thyroiditis (2019 Conference) (LDN, low dose naltrexone)

Igor Schwartzman, ND discusses the use of LDN in Hashimoto’s thyroiditis. He presents clinical characteristics, symptoms, and diagnostic criteria; possible causes, forms of thyroiditis, when LDN would benefit, dosing, and when to stop LDN.

Ginevra Liptan, MD - Turning down the volume on fibromyalgia pain (2019 Conference) (LDN, low dose naltrexone)

Ginevra Liptan, MD discusses fibromyalgia, including its symptoms, the CNS sensitization in fibromyalgia, how LDN can lessen fibromyalgia pain, and ways to avoid interactions between opiate-based pain medications and LDN. Case studies.

LDN 2019 Conference - Friday Morning Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

Debbie Hamilton, MD - Latest Th17 Research (2019 Conference) (LDN, low dose naltrexone)

Dana Keaton, ND - The scope of patient selection for LDN (2019 Conference) (LDN, low dose naltrexone)

Amy Lamb, Pharm - A Pharmacist's Perspective on Comprehensive Immune Health Consultations and Applications of LDN (2019 Conference) (LDN, low dose naltrexone)

Dr John Kim, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today I'm joined by Dr. John Kim from Georgia Integrative Medicine Clinic in the US. Thank you for joining us today. 

Vera - US: Dermatomyositis, Microscopic Colitis (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.